Spore powder of Ganoderma lucidum for Alzheimer's disease: A protocol for systematic review

BACKGROUND: Previous studies have reported that spore powder of Ganoderma lucidum (SPGL) may be effective for the treatment of Alzheimer's disease (AD). However, its efficacy is still inconclusive. Thus, this systematic review will aim to assess its efficacy and safety for AD. METHODS: We will...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Li-Hong, Wang, Chen, Qin, Li-Wei, Liang, Yan-Feng, Wang, Guo-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380698/
https://www.ncbi.nlm.nih.gov/pubmed/30702632
http://dx.doi.org/10.1097/MD.0000000000014382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380698/
https://www.ncbi.nlm.nih.gov/pubmed/30702632
http://dx.doi.org/10.1097/MD.0000000000014382

Ejemplares similares